NCT06186934
Recruiting
Not Applicable
Post Marketing Surveillance Study to Observe Safety and Effectiveness of NEPHOXIL ® in S. Korea Patients
ConditionsHyperphosphatemia
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Hyperphosphatemia
- Sponsor
- Kyowa Kirin Korea Co., Ltd.
- Enrollment
- 600
- Locations
- 1
- Primary Endpoint
- Serum phosphorus levels
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
The objective of this post-marketing surveillance (PMS) study is to assess the safety and effectiveness of Nephoxil capsule 500 mg (Ferric Citrate 500 mg, equivalent to 105 mg Ferric Iron) in routine clinical settings
Investigators
Eligibility Criteria
Inclusion Criteria
- •Adults 19 years of age or older
- •CKD patients undergoing hemodialysis to whom Nephoxil capsule administration is deemed necessary for improvement of hyperphosphatemia as per the determination of the investigator
- •Patients who received Nephoxil capsule for the first time according to the national approval after conclusion of the contract with the study institution
- •Those (or his / her legal guardian) who have agreed in writing to participate in the survey
Exclusion Criteria
- •Patients with contraindications to receive Nephoxil
- •Patients with hypersensitivity to the active substance or to any of the excipients
- •Patients with hypophosphatemia
- •Patients with abnormal iron metabolism or symptoms of excessive iron (e.g. hemochromatosis)
- •Patients who intend to use this drug for non-approved indications
- •Patients who participated in pre-market clinical trials with Nephoxil
- •Patients who took this drug before the starting day of this survey
Outcomes
Primary Outcomes
Serum phosphorus levels
Time Frame: 8 weeks
Effectiveness evaluation is performed based on Serum phosphorus levels (mg/dL) before and after Nephoxil administration. We collect the most recent measurements prior to the initial administration, and measurements after at least four and eight weeks of administration of Nephoxil
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
Not Applicable
Post Marketing Surveillance Study to Observe Safety and Effectiveness of CRYSVITA® in S. Korean PatientsFGF23-related Hypophosphataemic Rickets and OsteomalaciaNCT06202027Kyowa Kirin Korea Co., Ltd.100
Completed
Not Applicable
Evaluate the Safety and Effectiveness of Sovaldi in Participants With Chronic Hepatitis C Virus (HCV) Infection in KoreaHepatitis C VirusNCT02907996Gilead Sciences2,033
Terminated
Not Applicable
A Post Marketing Surveillance Study to Assess the Safety and Efficacy of Cetuximab Plus Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and NeckUnresectable Locally Advanced Squamous Cell Carcinoma of Head and NeckLA SCCHNNCT01303237Merck KGaA, Darmstadt, Germany88
Completed
Not Applicable
Primovist Regulatory Post Marketing Surveillance (PMS)LiverNCT00924248Bayer4,358
Completed
Not Applicable
A Study for PMS of AZL-M/CLD FDC in the Treatment of Participants With Essential HTN in South KoreaEssential HypertensionNCT04470830Celltrion Pharm, Inc.718